scholarly journals Study of implants for intraoperative hyperthermia

2021 ◽  
Vol 67 (2) ◽  
pp. 233-245
Author(s):  
Andrei Kaprin ◽  
Ilya Vasilchenko ◽  
Alexey Osintsev ◽  
Vladimir Braginsky ◽  
Vitaliy Rynk ◽  
...  

At the present time hyperthermia is recognized as one of the most promising methods in the combined treatment of malignant tumors. Nevertheless, for the most of existing methods for heating of tumor tissues it is rather difficult to realize the exact localization of heat exposure. The aim of this study is to compare two types of implants for intraoperative local tumor bed hyperthermia carried out using induction heating in an alternating magnetic field of the sub-MHz range. Composite implants of the first type are created on the base of a self-curing plastic mass mixed with electrically conductive ferromagnetic particles. The second type of implant is a hollow object with thin walls that follows the shape of the tumor. Implants of this type are filled with a liquid metal non-magnetic alloy with melting point below room temperature. The model implants were heated in a self-designed inductor with a short cylindrical coil 35 cm in diameter. Biological tissues were modeled using an ultrasound gel. Experimental results show that both types of implants were heated in an external alternating magnetic field with a frequency of 90 kHz and an amplitude not exceeding 4 kA/m up to temperatures that allow both traditional hyperthermia (tissue heating to 41-45 °C) and thermal ablation therapy (tissue heating to temperatures above 50 °C). Good agreement between the experimental data and model numerical calculations was obtained.

2018 ◽  
Vol 73 (7-8) ◽  
pp. 265-271 ◽  
Author(s):  
Natália Babincová ◽  
Paul Sourivong ◽  
Peter Babinec ◽  
Christian Bergemann ◽  
Melánia Babincová ◽  
...  

Abstract There is substantial evidence regarding enhanced antitumor cytotoxicity of selected chemotherapeutic agents by appropriate heat exposure (40–44°C). Based upon these results, the integration of hyperthermia as an additional treatment modality given simultaneously with systemic chemotherapy is currently of considerable interest. Hyperthermia can be induced by alternating magnetic field and magnetic nanoparticles. Thus, we have used thermosensitive magnetoliposomes that contained superparamagnetic iron oxide nanoparticles and doxorubicin for in vitro and in vivo therapy of rat glioma C6. The results showed that magnetoliposomes can be specifically heated to 43°C (phase transition temperature of a used lipid composition) in a few minutes, and during this, the encapsulated doxorubicin is released in a controllable manner. The in vitro experiments showed that the cell viability decreased to 79.2% after heat treatment alone and to 47.4% for doxorubicin-loaded magnetoliposomes without application of alternating magnetic field, while the combined treatment resulted in 17.3% cell viability. Also, in vivo results demonstrated that magnetic drug targeting has a strong antiglioma effect with a tumor volume growth inhibition and complete regression. Such targeted delivery and controlled release of anticancer agents would provide clinical advantages compared with currently available methods.


Sign in / Sign up

Export Citation Format

Share Document